Immunoregulatory Cells in Myasthenia Gravis

Area of Science:

• Immunology
• Neuroimmunology
• Autoimmune Diseases

Background:

• Myasthenia gravis (MG) is an autoimmune disorder targeting the neuromuscular junction.
• Antibodies against acetylcholine receptors are key diagnostic biomarkers but don't predict disease severity.
• Immunoregulatory cell populations are implicated in MG pathogenesis.

Purpose of the Study:

• To investigate the role of immunoregulatory cells in myasthenia gravis.
• To explore potential biomarkers for disease activity and treatment response.
• To understand the functional and numerical defects in regulatory T cells and myeloid-derived suppressor cells.

Main Methods:

• Characterization of immunophenotypes in human peripheral blood.
• Analysis of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs).
• Evaluation of follicular Tregs, follicular T helper cells, and IL-10-producing B cells in MG patients.

Main Results:

• CD4+FoxP3+ Tregs are functionally defective in MG, with unclear numerical changes.
• Adoptive transfer of Tregs or MDSCs suppresses experimental autoimmune MG (EAMG).
• Imbalances in follicular Tregs/T helper cells and inverse correlation of IL-10+ B cells with clinical status observed in MG patients.

Conclusions:

• Functional and numerical defects in immunoregulatory cells are evident in EAMG and human MG.
• The precise relationship between these cell defects and MG pathogenesis requires further study.
• Investigating these cells as potential biomarkers for disease activity in humans warrants further exploration.